Welcome to our dedicated page for Centrus Energy news (Ticker: LEU), a resource for investors and traders seeking the latest updates and insights on Centrus Energy stock.
Centrus Energy Corp. supplies nuclear fuel and services for the nuclear power industry. Its recurring news centers on Low-Enriched Uranium sales, separative work units, uranium enrichment, High-Assay, Low-Enriched Uranium, and Technical Solutions work that includes engineering, design, and manufacturing services for government and private-sector customers.
Company updates also cover financial results, revenue guidance, centrifuge manufacturing, enrichment-capacity expansion in Piketon, Ohio, and manufacturing activity in Oak Ridge, Tennessee. Partnership news has addressed engineering, project management, supply-chain coordination, artificial-intelligence tools, and other operational support for uranium-enrichment expansion.
Centrus Energy (LEU) signed a definitive multi-year contract to supply Antares Nuclear with High-Assay Low-Enriched Uranium (HALEU), with deliveries scheduled to begin before the end of the decade.
The agreement provides Antares with a reliable, U.S.-origin, “unobligated” HALEU source that can support advanced reactor projects for space and national security missions. The contract adds another HALEU customer to Centrus’ backlog and includes prepayments from Antares to help fund expansion of domestic enrichment capacity. Centrus is developing HALEU production at its American Centrifuge Plant, described as the only licensed HALEU production facility in the western world, and has launched a multi-billion-dollar expansion that includes large-scale HALEU and LEU production.
Centrus Energy (LEU) priced a $500 million underwritten public offering of Class A common stock and warrants on September 9, 2026.
The deal covers 500,000 shares of Class A common stock, 2,005,513 pre-funded warrants priced at $199.54 each (with a $0.10 exercise price), and common warrants to purchase up to 6,992,382 shares. The combined public offering price is $199.64 per share of common stock and accompanying common warrants. Investors in shares or pre-funded warrants receive a pro rata allocation of common warrants.
The common warrants are immediately exercisable in four series, each with an aggregate exercise price of approximately $500 million and per-share exercise prices of $226.8625, $272.2350, $317.6075 and $362.9800. Expirations range from two to five years after September 10, 2026, with each series split into two tranches. Closing is expected around September 11, 2026, and Centrus plans to use net proceeds for general corporate purposes.
Centrus Energy (LEU) has launched a proposed underwritten public offering of Class A common stock, pre-funded warrants and common warrants to purchase Class A common stock. Completion, size and terms of the offering are not yet determined and remain subject to market and other conditions.
The company plans to use net proceeds for general working capital and corporate purposes, which may include technology development and deployment, repayment or repurchase of debt, capital expenditures, and potential acquisitions or other opportunities. Guggenheim Securities is lead book-running manager and Barclays is book-running manager. The securities are registered under an effective shelf registration statement filed with the SEC on November 6, 2025.
Centrus Energy (LEU) and Radiant have signed a multi-year HALEU fuel supply contract for Radiant's Kaleidos microreactors. Centrus will begin delivering high-assay, low-enriched uranium before the end of the decade, providing an additional U.S.-origin fuel source to support commercial deployment of the Kaleidos fleet and potential national security uses. The agreement adds Radiant as another HALEU customer in Centrus' backlog and includes prepayments that support Centrus' domestic commercial enrichment capacity build-out.
For Radiant, the deal secures another domestic HALEU source as the company moves from its first Kaleidos test toward commercial and national security deployments. Because Centrus' technology and manufacturing supply chain are U.S.-origin, the enrichment supplied will be "unobligated," allowing use in national security applications. Radiant's transportable microreactors target remote locations, data centers, defense, and other commercial and industrial uses.
Centrus Energy (NYSE: LEU) hosted Ohio Governor Mike DeWine, Lt. Governor Jim Tressel, JobsOhio CEO J.P. Nauseef and other leaders at its uranium enrichment facility in Piketon, Ohio, to discuss Ohio's role in rebuilding the U.S. nuclear fuel supply chain and energy security.
Centrus highlighted its multi‑billion‑dollar expansion of the Piketon enrichment plant, announced in September 2025 and now underway. According to Centrus, the project is expected to support 1,000 construction jobs, create 300 new operating jobs, and retain 150 existing jobs, reinforcing Ohio's advanced manufacturing and workforce base.
X-energy (Nasdaq: XE) and Centrus Energy (NYSE: LEU) signed a definitive, long-term enrichment services agreement covering low-enriched uranium (LEU) and high-assay low-enriched uranium (HALEU) for X-energy’s Xe-100 advanced small modular reactor program. At full execution, X-energy said the deal meaningfully de-risks its Xe-100 project pipeline and secures HALEU to support a portion of the initial fuel needs for its 11.5 GW commercial pipeline.
HALEU from Centrus’s American Centrifuge Plant in Piketon, Ohio will be supplied to X-energy’s subsidiary TRISO-X for TRISO-X coated particle fuel fabrication in Oak Ridge, Tennessee, under a phased approach that scales production with X-energy’s commercial pipeline. TRISO-X holds a 40-year NRC special nuclear material license, and X-energy is advancing more than 11 GW of Xe-100 capacity in the U.S. and U.K. with projects involving Dow, Amazon and Centrica.
Centrus Energy (NYSE: LEU) signed a definitive agreement to provide X-energy with enrichment services for low-enriched uranium (LEU) and high-assay, low-enriched uranium (HALEU), with quantities expected to support X-energy’s initial Xe-100 small modular reactors and TRISO-X fuel deployments. X-energy will make prepayments to support Centrus’ domestic commercial enrichment capacity program. Centrus will supply LEU and HALEU from its American Centrifuge Plant in Pike County, Ohio, adding to its approximately $3 billion LEU and HALEU backlog, of which $2.4 billion is definitized, and aligning with its recently signed $900 million HALEU enrichment award with the U.S. Department of Energy.
Centrus Energy (NYSE: LEU) reported Q2 2026 revenue of $176.1 million, up 14% from $154.5 million in Q2 2025. GAAP net income was $16.8 million versus $28.9 million, while non-GAAP adjusted net income rose to $38.7 million from $34.5 million.
LEU segment revenue increased 22% to $153.4 million, including $53.4 million of uranium sales, while SWU revenue declined $25.7 million on 23% lower volume and 3% higher pricing. Technical Solutions revenue fell 21% to $22.7 million and shifted from a $3.2 million gross profit to a $1.7 million gross loss, largely tied to the HALEU Operation Contract.
Centrus signed a $900 million HALEU enrichment award with the U.S. Department of Energy, a large-scale commercial HALEU supply agreement that may include prepayments, and grew contingent LEU/HALEU backlog to $3.0 billion within a total company backlog of $4.5 billion.
For 2026, Centrus guides to $450–$500 million in total revenue and $350–$500 million in capital deployment, and expects to complete its first new centrifuge in Oak Ridge by year-end while significantly expanding hiring in Oak Ridge and Piketon.
Centrus Energy (NYSE: LEU) will webcast its quarterly conference call for shareholders and the financial community on Thursday, August 6, 2026, at 8:30 a.m. ET. The company will release its Q2 2026 earnings after market close on Wednesday, August 5, 2026, with live and replay access via the Investor Relations section of CentrusEnergy.com through August 19, 2026.
Centrus Energy (NYSE: LEU) will join the S&P SmallCap 600 Index before trading opens on July 14, 2026, replacing Whitestone REIT. The company highlights this as a milestone in its efforts to expand U.S. uranium enrichment, including a multi‑billion‑dollar plant expansion and a $900 million DOE task order.